🇬🇧·1d agoResearch
Risk assessment of secondary primary malignancies: results from two large prospective European cohorts
Publisher
n
npj Precision Oncology
UK
This page provides a limited summary and publisher metadata to support discovery before sending readers to the original article.
Read originalIn-platform summary, original article off-platform
This page presents the title, publisher metadata, and a limited summary excerpt to help users judge relevance first. Full-text reading stays on the publisher's original site.
Source route
Continue on nature.com
Leave the platform to read the original full article on the publisher site.
Source: npj Precision Oncology
Scope: Research
Related coverage
More related coverage
The Royal Marsden NHS Foundation Trust·18h ago
Screening Programme detects thousands of lung cancers early with potential to save lives
The programme uses low-dose computed tomography (LDCT) scans to identify lung cancer at an earlier,...
npj Precision Oncology·1d ago
AI-driven body composition atlas reveals its association with NSCLC immunotherapy outcome and molecular background: a multicenter study
npj Precision Oncology·1d ago
A comprehensive foundation model for generalizable cytogenetics in precision oncology with CHROMA
The Lancet·7h ago